Description: Apontis Pharma AG markets and sells medical drugs for indication fields of internal medicine in Germany. It develops, promotes, and sells a portfolio of single pills and other pharmaceutical products with a focus on cardiovascular diseases, such as hypertension, hyperlipidemia, and secondary prevention, as well as respiratory diseases and diabetes. The company is headquartered in Monheim am Rhein, Germany.
Home Page: apontis-pharma.de
Alfred-Nobel-Str. 10
Monheim am Rhein,
40789
Germany
Phone:
49 2173 8955 4949
Officers
Name | Title |
---|---|
Mr. Karlheinz Gast | Chairman of the Management Board & CEO |
Mr. Thomas Milz | Chief Product Officer & Deputy Chairman of Management Board |
Mr. Thomas Zimmermann | Chief Financial Officer |
Mr. Harald Weyand | Head of Marketing |
Dr. Matthias Wendl | Head of Sales |
Ms. Susanne Böhm | Head of HR |
Dr. Olaf Randerath | Head of Medicine |
Dr. Susanne Endreß | Head of QA, Drug Safety & Regulatory Affairs |
Exchange: XETRA
Country: DE : Germany
Currency: Euro (€)
Forward PE: | 0 |
---|---|
Trailing PE: | 20.4444 |
Price-to-Book MRQ: | 1.7527 |
Price-to-Sales TTM: | 1.3063 |
IPO Date: | |
Fiscal Year End: | December |
Full Time Employees: | 127 |